2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms
examine this vital industry in this 76 page report from The Wall Street Transcript.
Order this Report
Investing in Indian Pharma Prashant Nair - Citi Investment Research
Pharmaceutical Companies & Health Care Reform Plans Damien Conover - Morningstar
Uncertainty Breeds Opportunity in Specialty Pharma David Amsellem - Piper Jaffray & Co.
CEO Interviews (average 2,500 words): top management from 16 Sector Firms examine the outlook for its company and its sector. Firms interviewed include: Aeolus Pharmaceuticals, Inc., Alexza Pharmaceuticals, AmexDrug Corporation, BioClinica, Inc., BioPharm Asia, Inc., China Sky One Medical, Inc, Cortex Pharmaceuticals, Inc., GeoPharma, Inc., Mannatech, Inc., Medical Nutrition USA, Inc., NeoStem, Inc., Nutra Pharma, Provectus Pharmaceuticals, Inc, Quick-Med Technologies, Inc., Telik, Inc., and Winston Pharmaceuticals, Inc
Topics covered: Small-Cap Specialty Pharma - Patent Expiration - Pending Health Care Reform - Cultivating And Expanding R&D Pipelines - Chinese Drug Manufacturers - Brisk M&A Activity - Indian Pharma VS. U.S. Pharma - Competition From Generics - FDA Approval Process - Clinical Research Outsourcing Market - Stem Cell-Based Technology - Cancer Radiation Therapy - Expansion Into Asian Markets - Traditional Chinese Medicine VS. Western Medicine In Chinese Pharma
ORDER THIS REPORT NOW! CLICK HERE
Companies covered: Aeolus Pharmaceuticals (AOLS.OB); Nutra Pharma (NPHC.OB); Quick-Med Technologies (QMDT.OB); Abbott Labs (ABT); Alexza Pharmaceuticals (ALXA); AmexDrug Corporation (AXRX.OB); Aurobindo Pharma (AUROBINDOP.BO); BioClinica (BIOC); BioPharm Asia (BFAR.OB); Biocon (BIOCON.BO); Cephalon (CEPH); China Sky One Medical, Inc. (CSKI); Claris Lifesciences (CLARICH.BO); Cortex Pharmaceuticals (COR); Daiichi Sankyo (DSKYF.PK); Dr.Reddy's (RDY); Elan (Elan); Eli Lilly (LLY); Forest (FRX); GeoPharma (GORX); Glaxo (GSK); Glenmark (GLENMARK.BO); Johnson & Johnson (JNJ); Lupin (LUPINSL.BO); Mannatech (MTEX); Matrix Laboratories (ATRIXLAB.BO); Medical Nutrition (MDNU); Merck KGaA (MKGAY.PK); Mylan (MYL); NeoStem (NBS); Novartis (NVS); Pfizer (PFE); Piramal Healthcare (PIRAMALHE.BO); Provectus Pharmaceuticals (PVCT.OB); Ranbaxy (RANBAXY.BO); Salix Pharmaceuticals (SLXP); Shire (SHPGY); Telik (TELK); Winston Pharmaceuticals (WPHM.OB).
